Alternative Approaches to Dose–Response Modeling of Toxicological Endpoints for Risk Assessment: Nonmonotonic Dose Responses for Endocrine Disruptors

Characterization of the dose response is an important step in the risk assessment process. For years, risk assessment agencies have relied on the toxicological principle that “the dose makes the poison” and that effects scale linearly with dose. Yet, there are numerous examples from vitamins, essential nutrients, hormones, and environmental chemicals that defy this simplistic expectation. Nonmonotonic dose responses have been reported in hundreds of studies of endocrine-disrupting chemicals, and further evaluations have revealed a number of mechanisms responsible for these curves. This article reviews evidence supporting the existence of nonmonotonic dose responses and discusses why these have continued to generate controversy. It concludes with an explanation of how deviations from linear dose responses can make the determination of ”safe” levels of exposure difficult using traditional risk assessment procedures.

[1]  J. Bucher,et al.  Consortium-Based Science: The NIEHS’s Multipronged, Collaborative Approach to Assessing the Health Effects of Bisphenol A , 2012, Environmental health perspectives.

[2]  C. L. Sanders,et al.  Commentary: Ethical Issues of Current Health-Protection Policies on Low-Dose Ionizing Radiation , 2014, Dose-response : a publication of International Hormesis Society.

[3]  A. Ismail,et al.  Nuclear hormone receptor degradation and gene transcription: An update , 2005, IUBMB life.

[4]  Rosalind,et al.  Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. , 1996, Environmental health perspectives.

[5]  M. Fallat,et al.  Fertility and Sterility , 1950, Nature.

[6]  M. Lohse,et al.  Molecular mechanisms of membrane receptor desensitization. , 1993, Biochimica et biophysica acta.

[7]  Anna Beronius,et al.  Facilitating the use of non‐standard in vivo studies in health risk assessment of chemicals: a proposal to improve evaluation criteria and reporting , 2014, Journal of applied toxicology : JAT.

[8]  Laura N. Vandenberg,et al.  Peer-reviewed and unbiased research, rather than ‘sound science’, should be used to evaluate endocrine-disrupting chemicals , 2016, Journal of Epidemiology & Community Health.

[9]  L. Vandenberg,et al.  Non-Monotonic Dose Responses in Studies of Endocrine Disrupting Chemicals: Bisphenol a as a Case Study , 2014, Dose-response : a publication of International Hormesis Society.

[10]  Taisen Iguchi,et al.  The Impact of Endocrine Disruption: A Consensus Statement on the State of the Science , 2013, Environmental health perspectives.

[11]  D. Michaels Fomenting scientific uncertainty by David Michaels photographs by mindy jones is their product , 2005 .

[12]  N. Olea,et al.  Negative controls of cell proliferation: human prostate cancer cells and androgens. , 1989, Cancer research.

[13]  B. O’Malley,et al.  Proteasome-dependent degradation of the human estrogen receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Laura N. Vandenberg,et al.  Chlorinated persistent organic pollutants, obesity, and type 2 diabetes. , 2014, Endocrine reviews.

[15]  Ruili Huang,et al.  Predictive endocrine testing in the 21st century using in vitro assays of estrogen receptor signaling responses. , 2014, Environmental science & technology.

[16]  R. Melnick,et al.  Biochemical origins of the non-monotonic receptor-mediated dose-response. , 2002, Journal of molecular endocrinology.

[17]  R. Tyl Basic Exploratory Research versus Guideline-Compliant Studies Used for Hazard Evaluation and Risk Assessment: Bisphenol A as a Case Study , 2009, Environmental health perspectives.

[18]  Chuck Yu,et al.  Environmental health perspectives in Central China , 2014 .

[19]  Ocspp Us Epa About the TSCA Chemical Substance Inventory , 2014 .

[20]  R. Melnick,et al.  Fundamental Flaws of Hormesis for Public Health Decisions , 2005, Environmental health perspectives.

[21]  Shuk-Mei Ho,et al.  Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. , 2007, Reproductive toxicology.

[22]  K. Korach,et al.  Tissue Distribution and Quantitative Analysis of Estrogen Receptor-α (ERα) and Estrogen Receptor-β (ERβ) Messenger Ribonucleic Acid in the Wild-Type and ERα-Knockout Mouse. , 1997, Endocrinology.

[23]  Laura N. Vandenberg,et al.  Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. , 2013, Reproductive toxicology.

[24]  H. Kinyamu,et al.  Estrogen Receptor-Dependent Proteasomal Degradation of the Glucocorticoid Receptor Is Coupled to an Increase in Mdm2 Protein Expression , 2003, Molecular and Cellular Biology.

[25]  L. Stanley,et al.  PXR and CAR: Nuclear Receptors which Play a Pivotal Role in Drug Disposition and Chemical Toxicity , 2006, Drug metabolism reviews.

[26]  U. Querfeld,et al.  Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window , 2010, Pediatric Nephrology.

[27]  J. Toppari,et al.  Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. , 2015, Endocrine reviews.

[28]  Regulatory Forum Opinion Piece* , 2013, Toxicologic pathology.

[29]  O. Olujimi,et al.  Endocrine disrupting chemicals (phenol and phthalates) in the South African environment: a need for more monitoring , 2010 .

[30]  T J Woodruff,et al.  Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. , 2012, Endocrinology.

[31]  M. Hanson,et al.  Altered regional blood flow in the fetus: the origins of cardiovascular disease? , 2004, Acta paediatrica.

[32]  David M. Reif,et al.  Endocrine Profiling and Prioritization of Environmental Chemicals Using ToxCast Data , 2010, Environmental health perspectives.

[33]  B. Kobilka,et al.  Antagonist-dependent and -independent steps in the mechanism of adrenergic receptor internalization. , 1994, The Journal of biological chemistry.

[34]  Carlos Sonnenschein,et al.  Perinatally Administered Bisphenol A as a Potential Mammary Gland Carcinogen in Rats , 2013, Environmental health perspectives.

[35]  David Michaels,et al.  Doubt is their product. , 2005, Scientific American.

[36]  C. Sonnenschein,et al.  Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[37]  Laura N. Vandenberg,et al.  Science and policy on endocrine disrupters must not be mixed: a reply to a “common sense” intervention by toxicology journal editors , 2013, Environmental Health.

[38]  Amy D. Kyle,et al.  Meeting Report: Moving Upstream—Evaluating Adverse Upstream End Points for Improved Risk Assessment and Decision-Making , 2008, Environmental health perspectives.

[39]  J. Gustafsson,et al.  Expression of estrogen receptor alpha and beta during mouse embryogenesis , 1999, Mechanisms of Development.

[40]  C. Sonnenschein,et al.  The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. , 2000, Environmental health perspectives.

[41]  K. Coser,et al.  Importance of dosage standardization for interpreting transcriptomal signature profiles: Evidence from studies of xenoestrogens , 2006, Proceedings of the National Academy of Sciences.

[42]  R. Zoeller,et al.  Endocrine disruption for endocrinologists (and others). , 2006, Endocrinology.

[43]  J. Bloomquist,et al.  Selective effects of insecticides on nigrostriatal dopaminergic nerve pathways. , 2002, Neurotoxicology.

[44]  D. Barker,et al.  The thrifty phenotype hypothesis. , 2001, British medical bulletin.

[45]  Ana M Soto,et al.  Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. , 2009, Endocrine reviews.

[46]  David Michaels,et al.  Manufactured Uncertainty , 2006, Annals of the New York Academy of Sciences.

[47]  Åke Bergman,et al.  State of the Science of Endocrine Disrupting Chemicals - 2012 , 2012 .

[48]  Koji Arizono,et al.  Why Public Health Agencies Cannot Depend on Good Laboratory Practices as a Criterion for Selecting Data: The Case of Bisphenol A , 2008, Environmental health perspectives.

[49]  Laura N. Vandenberg,et al.  The mammary gland response to estradiol: Monotonic at the cellular level, non-monotonic at the tissue-level of organization? , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[50]  F. Grün,et al.  Endocrine disrupters as obesogens , 2009, Molecular and Cellular Endocrinology.

[51]  Julie E. Goodman,et al.  A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters” , 2012, Critical reviews in toxicology.

[52]  E. Bülbring,et al.  The estimation of œstrin and of male hormone in oily solution , 1935, The Journal of physiology.

[53]  R. Dorfman,et al.  THE NATURE OF THE ESTROGENIC SUBSTANCE IN HUMAN MALE URINE AND BULL TESTIS , 1935 .

[54]  Laura N. Vandenberg,et al.  Human exposures to bisphenol A: mismatches between data and assumptions , 2013, Reviews on environmental health.

[55]  E. Barrett-Connor,et al.  Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. , 2010, The Journal of clinical endocrinology and metabolism.

[56]  L. Ellestad,et al.  Sources, concentrations, and exposure effects of environmental gestagens on fish and other aquatic wildlife, with an emphasis on reproduction. , 2014, General and comparative endocrinology.

[57]  K A Thayer,et al.  Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[58]  J. Škarda,et al.  Mouse bioassay for in vivo screening of oestrogen and progesterone antagonists. , 2006, Journal of veterinary medicine. A, Physiology, pathology, clinical medicine.

[59]  J. Škarda Sensitivity and specificity of the bioassay of estrogenicity in mammary gland and seminal vesicles of male mice. , 2002, Physiological research.

[60]  P. Bossuyt,et al.  Blood pressure response to psychological stressors in adults after prenatal exposure to the Dutch famine , 2006, Journal of hypertension.

[61]  P. Boffetta,et al.  Comments on the opinions published by Bergman et al. (2015) on Critical Comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals (Lamb et al., 2014). , 2015, Regulatory toxicology and pharmacology : RTP.

[62]  Kellyn S. Betts,et al.  Tox21 to Date: Steps toward Modernizing Human Hazard Characterization , 2013, Environmental health perspectives.

[63]  R. G. York,et al.  Male reproductive system parameters in a two-generation reproduction study of ammonium perfluorooctanoate in rats and human relevance. , 2010, Toxicology.

[64]  M. Beck,et al.  An oral developmental neurotoxicity study of decabromodiphenyl ether (DecaBDE) in rats. , 2011, Birth defects research. Part B, Developmental and reproductive toxicology.

[65]  Patience Browne,et al.  Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model. , 2015, Environmental science & technology.

[66]  Clive Osmond,et al.  Early onset of coronary artery disease after prenatal exposure to the Dutch famine. , 2006, The American journal of clinical nutrition.

[67]  Laura N. Vandenberg,et al.  Non-monotonic dose responses in EDSP Tier 1 guideline assays , 2014 .

[68]  Naomi Oreskes,et al.  Viewpoint: Why Disclosure Matters. , 2015, Environmental science & technology.

[69]  Laura N. Vandenberg,et al.  Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals , 2015, Reviews in Endocrine and Metabolic Disorders.

[70]  Sharon Munn,et al.  Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary. , 2013, Chemosphere.

[71]  P. Ricci,et al.  Endocrine disruptors , 1996 .

[72]  W. Xie,et al.  Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism. , 2004, Drug discovery today.

[73]  R. Slama,et al.  Science-based regulation of endocrine disrupting chemicals in Europe: which approach? , 2016, The lancet. Diabetes & endocrinology.

[74]  Laura N Vandenberg,et al.  Assessing dose–response relationships for endocrine disrupting chemicals (EDCs): a focus on non-monotonicity , 2015, Environmental Health.

[75]  A. Gore Editorial: an international Riposte to Naysayers of endocrine-disrupting chemicals. , 2013, Endocrinology.

[76]  Kenny S. Crump,et al.  Calculation of Benchmark Doses from Continuous Data , 1995 .

[77]  David M. Reif,et al.  Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets. , 2011, Toxicology.

[78]  J. Haseman,et al.  Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. , 2002, Environmental health perspectives.

[79]  Julia A. Taylor,et al.  Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation. , 2013, Reproductive toxicology.

[80]  W. Chang,et al.  Estimates of Relative Risks for Cancers in a Population after Prolonged Low-Dose-Rate Radiation Exposure: A Follow-up Assessment from 1983 to 2005 , 2008, Radiation research.

[81]  B. Blumberg,et al.  On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens , 2016, Environmental health perspectives.

[82]  J. Borzelleca Paracelsus: herald of modern toxicology. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[83]  P. Hof,et al.  Policy Decisions on Endocrine Disruptors Should Be Based on Science across Disciplines: A Response to Dietrich et al. , 2013, Hormone Research in Paediatrics.

[84]  David M. Reif,et al.  Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management. , 2012, Chemical research in toxicology.

[85]  Laura N. Vandenberg,et al.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. , 2012, Endocrine reviews.

[86]  C. Brisken,et al.  Does Cancer Start in the Womb? Altered Mammary Gland Development and Predisposition to Breast Cancer due to in Utero Exposure to Endocrine Disruptors , 2013, Journal of Mammary Gland Biology and Neoplasia.

[87]  P. Bossuyt,et al.  Reduced intima media thickness in adults after prenatal exposure to the Dutch famine. , 2007, Atherosclerosis.

[88]  Laura N. Vandenberg,et al.  Designing Endocrine Disruption Out of the Next Generation of Chemicals. , 2013, Green chemistry : an international journal and green chemistry resource : GC.

[89]  Salomon Sand,et al.  The Benchmark Dose Method—Review of Available Models, and Recommendations for Application in Health Risk Assessment , 2003, Critical reviews in toxicology.

[90]  H. Steven Wiley,et al.  Receptor downregulation and desensitization enhance the information processing ability of signalling receptors , 2007, BMC Syst. Biol..

[91]  Christopher J Borgert,et al.  Potency matters: thresholds govern endocrine activity. , 2013, Regulatory toxicology and pharmacology : RTP.

[92]  John Peterson Myers,et al.  A Clash of Old and New Scientific Concepts in Toxicity, with Important Implications for Public Health , 2009, Environmental health perspectives.

[93]  R. Slama,et al.  EU regulation of endocrine disruptors: a missed opportunity. , 2016, The lancet. Diabetes & endocrinology.

[94]  J. Gustafsson,et al.  Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. , 1997, Endocrinology.

[95]  哲郎 小川,et al.  Developmental Origins of Health and Disease説の責任遺伝子の網羅的検索 , 2011 .

[96]  J. Oehlmann,et al.  Reproductive stimulation by low doses of xenoestrogens contrasts with the view of hormesis as an adaptive response , 2005, Human & experimental toxicology.

[97]  D. Dix,et al.  The ToxCast program for prioritizing toxicity testing of environmental chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[98]  A. Gore Neuroendocrine targets of endocrine disruptors , 2010, Hormones.

[99]  K. Hong,et al.  Cellular Mechanism of the Nonmonotonic Dose Response of Bisphenol A in Rat Cardiac Myocytes , 2014, Environmental health perspectives.

[100]  J. Gustafsson,et al.  Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. , 1997, Endocrinology.

[101]  Paul Mushak,et al.  How prevalent is chemical hormesis in the natural and experimental worlds? , 2013, The Science of the total environment.

[102]  Richard A Becker,et al.  Evaluation of EPA's Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results. , 2011, Regulatory toxicology and pharmacology : RTP.

[103]  A C Gore,et al.  EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. , 2015, Endocrine reviews.

[104]  Adrian V. Lee,et al.  Policy decisions on endocrine disruptors should be based on science across disciplines , 2013, European journal of endocrinology.

[105]  D. Dietrich,et al.  Endocrine disruption: fact or urban legend? , 2013, Toxicology letters.

[106]  C. Sonnenschein,et al.  Does breast cancer start in the womb? , 2008, Basic & clinical pharmacology & toxicology.

[107]  B. Blumberg,et al.  Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. , 2011, Birth defects research. Part C, Embryo today : reviews.

[108]  Ruili Huang,et al.  Using in Vitro High Throughput Screening Assays to Identify Potential Endocrine-Disrupting Chemicals , 2012, Environmental health perspectives.

[109]  K. Dahlman-Wright,et al.  Review Nuclear Receptor Signaling | The Open Access Journal of the Nuclear Receptor Signaling Atlas Estrogen receptor β: an overview and update , 2022 .

[110]  Taisen Iguchi,et al.  A path forward in the debate over health impacts of endocrine disrupting chemicals , 2014, Environmental Health.

[111]  Claude Emond,et al.  Non-monotonic dose-response relationships and endocrine disruptors: a qualitative method of assessment , 2015, Environmental Health.

[112]  L. Giudice,et al.  Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. , 2008, Fertility and sterility.

[113]  Edward J Calabrese,et al.  Toxicology rewrites its history and rethinks its future: Giving equal focus to both harmful and beneficial effects , 2011, Environmental toxicology and chemistry.

[114]  K. Wallen The Organizational Hypothesis: Reflections on the 50th anniversary of the publication of Phoenix, Goy, Gerall, and Young (1959) , 2009, Hormones and Behavior.

[115]  M D Shelby,et al.  Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. , 1996, Environmental Health Perspectives.

[116]  K. Korach,et al.  Differential Estrogenic Actions of Endocrine-Disrupting Chemicals Bisphenol A, Bisphenol AF, and Zearalenone through Estrogen Receptor α and β in Vitro , 2012, Environmental Health Perspectives.

[117]  Kristina A Thayer,et al.  Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. , 2003, Environmental health perspectives.

[118]  Philippe Grandjean,et al.  Developmental Origins of Health and Disease: Integrating Environmental Influences. , 2015, Endocrinology.

[119]  D J Barker,et al.  Is lifespan determined in utero? , 1997, Archives of disease in childhood. Fetal and neonatal edition.

[120]  Paul Mushak,et al.  Hormesis and Its Place in Nonmonotonic Dose–Response Relationships: Some Scientific Reality Checks , 2007, Environmental health perspectives.

[121]  K. Fent,et al.  Highly active human pharmaceuticals in aquatic systems: A concept for their identification based on their mode of action. , 2010, Aquatic toxicology.

[122]  Laura N. Vandenberg,et al.  Perinatal Bisphenol A Exposure Increases Estrogen Sensitivity of the Mammary Gland in Diverse Mouse Strains , 2007, Environmental health perspectives.

[123]  L. Giudice,et al.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement. , 2009, Endocrine reviews.

[124]  Julie E Goodman,et al.  Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made? , 2012, Regulatory toxicology and pharmacology : RTP.

[125]  Bruce Blumberg,et al.  Endocrine disrupting chemicals and disease susceptibility , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[126]  Laura N. Vandenberg,et al.  Developmental origins of health and disease: a paradigm for understanding disease cause and prevention , 2015, Current opinion in pediatrics.

[127]  Sudha Seshadri,et al.  Thyroid function and the risk of Alzheimer disease: the Framingham Study. , 2008, Archives of internal medicine.

[128]  R. Neubig,et al.  ANG II type 1 receptor downregulation does not require receptor endocytosis or G protein coupling. , 2001, American journal of physiology. Cell physiology.

[129]  L. Birnbaum Environmental Chemicals: Evaluating Low-Dose Effects , 2012, Environmental health perspectives.

[130]  L. Giudice,et al.  State of the Science of Endocrine Disrupting Chemicals - 2012 , 2012 .

[131]  A. Gore,et al.  Endocrine-disrupting chemicals , 2022, Current Biology.

[132]  Ruili Huang,et al.  The Tox21 robotic platform for the assessment of environmental chemicals--from vision to reality. , 2013, Drug discovery today.

[133]  W. Welshons,et al.  Low-dose bioactivity of xenoestrogens in animals: fetal exposure to low doses of methoxychlor and other xenoestrogens increases adult prostate size in mice , 1999, Toxicology and industrial health.

[134]  Julie E Goodman,et al.  Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals - 2012. , 2014, Regulatory toxicology and pharmacology : RTP.

[135]  Laura N. Vandenberg,et al.  Low-dose effects of hormones and endocrine disruptors. , 2014, Vitamins and hormones.

[136]  Laura N. Vandenberg,et al.  Low dose effects of bisphenol A , 2013 .

[137]  D. J. Barker The origins of the developmental origins theory , 2007, Journal of internal medicine.

[138]  W. Welshons,et al.  Implications for human health of the extensive bisphenol A literature showing adverse effects at low doses: a response to attempts to mislead the public. , 2005, Toxicology.

[139]  J. Barnett,et al.  Two-generation reproductive and developmental toxicity assessment of dietary N-acetyl-L-aspartic acid in rats. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[140]  G. B. Gori,et al.  Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[141]  N. Bunnett,et al.  Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. , 1997, The Biochemical journal.

[142]  Meena Kumari,et al.  A nonlinear relationship of generalized and central obesity with diurnal cortisol secretion in the Whitehall II study. , 2010, The Journal of clinical endocrinology and metabolism.

[143]  D. Tillitt,et al.  Effects of the environmental estrogenic contaminants bisphenol A and 17α-ethinyl estradiol on sexual development and adult behaviors in aquatic wildlife species. , 2015, General and comparative endocrinology.

[144]  A. Kortenkamp,et al.  Statistical Power Considerations Show the Endocrine Disruptor Low-Dose Issue in a New Light , 2007, Environmental health perspectives.

[145]  Nancy G Doerrer,et al.  Identification and characterization of adverse effects in 21st century toxicology. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[146]  J. Gustafsson,et al.  Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues , 2008, Journal of internal medicine.

[147]  A. Hanberg,et al.  Bridging the gap between academic research and regulatory health risk assessment of Endocrine Disrupting Chemicals. , 2014, Current opinion in pharmacology.

[148]  Nancy G. Doerrer,et al.  Identification and Characterization of Adverse Effects in 21 st Century Toxicology , 2012 .

[149]  D. Levy,et al.  Plasma Leptin Levels and Incidence of Heart Failure, Cardiovascular Disease, and Total Mortality in Elderly Individuals , 2008, Diabetes Care.

[150]  R. Tyl In honor of the Teratology Society's 50th anniversary: The role of Teratology Society members in the development and evolution of in vivo developmental toxicity test guidelines. , 2010, Birth defects research. Part C, Embryo today : reviews.

[151]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[152]  A. Hanberg,et al.  Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European Union. , 2009, Regulatory toxicology and pharmacology : RTP.

[153]  C. Sonnenschein,et al.  Androgen-induced proliferative quiescence in prostate cancer cells: the role of AS3 as its mediator. , 2000, Proceedings of the National Academy of Sciences of the United States of America.